Corbus Pharmaceuticals Holdings, Inc. Notes Payable
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Notes Payable of $39.04 thousand as of 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:NotesPayable · last filed 2017-11-08
- 2017-06-30: Notes Payable $39.04K.
- 2017-03-31: Notes Payable $155.73K.
- 2016-12-31: Notes Payable $271.76K.
- 2016-06-30: Notes Payable $23.33K.
| Period end | Notes Payable |
|---|---|
| 2017-06-30 | $39.04K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $155.73K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $271.76K 10-Q · filed 2017-11-08 |
| 2016-06-30 | $23.33K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $92.96K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $162.02K 10-K · filed 2017-03-08 |
| 2015-03-31 | $72.49K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $144.39K 10-K · filed 2016-03-28 |
| 2014-09-30 | $75.24K 10-Q · filed 2014-11-13 |
| 2013-12-31 | $638.08K 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |